| Ident. | Authors (with country if any) | Title |
|---|
| 000B45 (2012) |
JIANZHONG SHI [République populaire de Chine] ; ZHIYUAN WEN [République populaire de Chine] ; JING GUO [République populaire de Chine] ; YING ZHANG [République populaire de Chine] ; GUOHUA DENG [République populaire de Chine] ; YUELONG SHU [République populaire de Chine] ; DAYAN WANG [République populaire de Chine] ; YONGPING JIANG [République populaire de Chine] ; Yoshihiro Kawaoka [Japon] ; ZHIGAO BU [République populaire de Chine] ; HUALAN CHEN [République populaire de Chine] | Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice |
| 000D62 (2011) |
Larisa Rudenko [Russie, Australie] ; Han Van Den Bosch [Pays-Bas] ; Irina Kiseleva [Russie, Australie] ; Alexander Mironov [Russie] ; Anatoly Naikhin [Russie] ; Natalie Larionova [Russie] ; Dimitry Bushmenkov [Russie] | Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries |
| 000D64 (2011) |
Kortney M. Gustin [Géorgie] ; Taronna R. Maines [Géorgie] ; Jessica A. Belser [Géorgie] ; Neal Van Hoeven [Géorgie] ; XUIHUA LU [Géorgie] ; LIBO DONG [Géorgie] ; Irina Isakova-Sivak [Géorgie, Russie] ; Li-Mei Chen [Géorgie] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Nancy J. Cox [Géorgie] ; Terrence M. Tumpey [Géorgie] ; Alexander I. Klimov [Géorgie] ; Larisa Rudenko [Russie] ; Ruben O. Donis [Géorgie] ; Jacqueline M. Katz [Géorgie] | Comparative Immunogenicity and Cross-Clade Protective Efficacy of Mammalian Cell-Grown Inactivated and Live Attenuated H5N1 Reassortant Vaccines in Ferrets |
| 000F88 (2010) |
J. Theo [Pays-Bas] ; M. Voeten [Pays-Bas] ; Irina V. Kiseleva [Russie] ; Harrie L. Glansbeek [Pays-Bas] ; Stephanie M. C. Basten [Pays-Bas] ; Sandra K. M. Drieszen-Van Der Cruijsen [Pays-Bas] ; Larisa G. Rudenko [Russie] ; Han Van Den Bosch [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] | Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model |
| 000F90 (2010) |
ZHONGYING CHEN [États-Unis] ; WEIJIA WANG [États-Unis] ; HELEN ZHOU [États-Unis] ; Amorsolo L. Jr Suguitan [États-Unis] ; Cindy Shambaugh [États-Unis] ; Lomi Kim [États-Unis] ; Jackie Zhao [États-Unis] ; George Kemble [États-Unis] ; HONG JIN [États-Unis] | Generation of Live Attenuated Novel Influenza Virus A/California/7/09 (H1N1) Vaccines with High Yield in Embryonated Chicken Eggs |
| 000F92 (2010) |
Alicia Solorzano [États-Unis] ; JIANQIANG YE [États-Unis] ; Daniel R. Perez [États-Unis] | Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu |
| 000F93 (2010) |
Ji-Young Min [États-Unis] ; Leatrice Vogel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; BIN LU [États-Unis] ; David Swayne [États-Unis] ; HONG JIN [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | A Live Attenuated H7N7 Candidate Vaccine Virus Induces Neutralizing Antibody That Confers Protection from Challenge in Mice, Ferrets, and Monkeys |
| 001203 (2009) |
Kawsar R. Talaat [États-Unis] ; Ruth A. Karron [États-Unis] ; Karen A. Callahan [États-Unis] ; Catherine J. Luke [États-Unis] ; Susan C. Dilorenzo [États-Unis] ; Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; HONG JIN [États-Unis] ; Kathy L. Coelingh [États-Unis] ; Brian R. Murphy [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults |
| 001569 (2006) |
J. A. Desheva [Russie] ; X. H. Lu [États-Unis] ; A. R. Rekstin [Russie] ; L. G. Rudenko [Russie] ; D. E. Swayne [États-Unis] ; N. J. Cox [États-Unis] ; J. M. Katz [États-Unis] ; A. I. Klimov [États-Unis] | Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential |
| 001737 (2003) |
H. Chen [États-Unis] ; Y. Matsuoka [États-Unis] ; David Swayne [États-Unis] ; Q. Chen [États-Unis] ; N. J. Cox [États-Unis] ; B. R. Murphy [États-Unis] ; K. Subbarao [États-Unis] | Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate |
| 001739 (2003) |
G. A. Marsh [Australie] ; J. M. Watson [Australie] ; W. E. White [Australie] ; G. A. Tannock [Australie] | An evaluation of the genetic stability and pathogenicity of the Russian cold-adapted influenza A donor strains A/Leningrad/134/17/57 and A/Leningrad/134/47/57 in ferrets |
| 001B55 (1997) |
Brian R. Murphy [États-Unis] ; Eun Ju Park [États-Unis] ; Paul Gottlieb [États-Unis] ; Kanta Subbarao [États-Unis] | An influenza A live attenuated reassortant virus possessing three temperature-sensitive mutations in the PB2 polymerase gene rapidly loses temperature sensitivity following replication in hamsters |
| 001C27 (1996) |
Shinichi Sakamoto [Japon] ; Yoichiro Kino [Japon] ; Testuya Oka [Japon] ; M. Louise Herlocher [États-Unis] ; Hunien F. Maassab [États-Unis] | Gene analysis of reassortant influenza virus by RT-PCR followed by restriction enzyme digestion |
| 001D33 (1995) |
G. A. Tannock [Australie] ; J. R. Romanova [Russie] ; J. A. Paul [Australie] | The immunogenicity of reassortants of the cold-adapted influenza A master strain A/Ann Arbor/6/60 is determined by both the genes for cold-adaptation and the haemagglutinin gene |
| 001F37 (1992) |
Alexander I. Klimov [Russie] ; Nancy J. Cox [États-Unis] ; Wagner V. Yotov [Russie] ; Elisabet Rocha [États-Unis] ; Galina I. Alexandrova [Russie] ; Alan P. Kendal [États-Unis] | Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus |
| 002063 (1991) |
B. Panzing [Allemagne] ; K. B. Lisovskaya ; B. Herrman ; A. Klimov ; L. Döhner | Further studies on cold adapted variants of human influenza virus A/Krasnodar/101/59 (H2N2) with special reference to genetic stability of attenuation markers |
| 002250 (1988) |
Nancy J. Cox [États-Unis] ; Fumio Kitame [Japon] ; Alan P. Kendal [États-Unis] ; Hunein F. Maassab [États-Unis] ; Clayton Naeve [États-Unis] | Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2) |
| 002271 (1988) |
M. H. Snyder ; R. F. Betts ; D. Deborde ; E. L. Tierney ; M. L. Clements ; D. Herrington ; S. D. Sears ; R. Dolin ; H. F. Maassab ; B. R. Murphy | Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines |
| 002334 (1987) |
E. E. Rozina ; O. E. Khudaverdyan ; Yu. Z. Ghendon | Clinical and morphologic studies on the guinea pig eye infected with human influenza virus strains of different virulence |
